solution by Industry

Turnkey Injectable & IV Solution Production Lines — From Design to GMP Delivery

Integrated manufacturing systems built to EU GMP, US FDA cGMP, WHO & PIC/S standards — trusted by pharmaceutical producers in 60+ countries.

Industry Overview

The Industry at a Glance

The global injectable drug delivery market reached $690 billion in 2025 and is projected to surpass $1 trillion by 2030, growing at a CAGR of 8.4%. Asia-Pacific is projected to register the fastest growth owing to expanding pharmaceutical manufacturing and rising chronic disease burden. For manufacturers in emerging markets, investing in GMP-compliant, locally built injectable and IV solution lines is the most strategic path to reducing import dependency, gaining regulatory approval, and capturing market share.

Product Applications

Where Our Products Are Used

  • 1

    IV Infusion Production Lines

    Complete systems for Non-PVC soft bag, PP bottle, and glass bottle IV solutions, from compounding to filling and sterilization.
  • 2

    Ampoule & Vial Filling Lines

    High-speed aseptic filling and sealing lines for injectable formulations, fully compliant with cGMP requirements.
  • 3

    Oral Solid Dosage (OSD) Plants

    Integrated granulation, tablet pressing, capsule filling, coating, and blister packaging for tablets and capsules.
  • 4

    Pharmaceutical Water Treatment Systems

    Purified water (PW) and water for injection (WFI) generation, storage, and distribution systems meeting pharmacopeia standards.
  • 5

    Cleanroom & HVAC Engineering

    Full facility design including classified cleanrooms, HVAC zoning, and environmental monitoring systems.

technology

Pain Points & Solutions

  • Pain Point: Navigating multi-country GMP certification delays market entry by years.

    Solution: Every line is pre-engineered to simultaneously meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S — built to pass audits on the first attempt.

  • Pain Point: Sourcing from multiple equipment vendors creates integration failures and unclear accountability.

    Solution: Single-source turnkey delivery — process design, equipment manufacturing, cleanroom, water systems, and validation under one contract.

  • Pain Point: Lack of local technical expertise stalls commissioning and daily operations.

    Solution: Complete technology transfer, hands-on operator training, and dedicated after-sales support from project handover onward.

  • Pain Point: Scaling production capacity without disrupting existing GMP compliance.

    Solution: Modular line configurations enable phased expansion with minimal downtime and seamless regulatory continuity.

Advantages

Why Choose Us

  • 20 years of focused expertise in injectable & IV manufacturing engineering

  • 2,500+ production lines delivered and operating across 60+ countries

  • 4 self-owned factories — pharma machinery, medical devices, water treatment, packaging — ensuring full vertical quality control

  • Multi-standard GMP compliance (EU, FDA, WHO, PIC/S) engineered into every project

  • End-to-end turnkey service — from URS and process design through FAT/SAT to IQ/OQ/PQ validation

  • Responsive global support — remote diagnostics, spare parts logistics, and regional on-site service teams

case

Success Snapshot

  • National Pharmaceutical Manufacturer

    Central Asia

    Delivered a complete pharmaceutical factory including 2 Non-PVC soft bag IV lines and 4 ampoule filling lines. The facility became a regional production hub, significantly reducing the country’s reliance on imported IV solutions.

  • Government-Backed Pharma Enterprise

    Southeast Asia

    Completed a phased PP bottle IV solution turnkey project — from 8,000 bottles/hour in Phase 1 to 12,000 bottles/hour in Phase 2. The client passed national GMP inspection on the first submission.

testimony

Trusted by Industry Leaders

  • “IVEN managed everything — cleanroom, water system, production lines, and validation — under one roof. We went from an empty site to a GMP-ready factory in 15 months.”

    Mr. K

    General Manager

  • “After evaluating European and Chinese suppliers, we chose IVEN for their turnkey integration and post-commissioning training. Our operators were production-ready within weeks.”

    Ms. D

    VP of Operations

Support

FAQ

All lines are designed to simultaneously satisfy EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP requirements.

Yes. Every project begins with a tailored URS and site assessment matched to your capacity targets and building constraints.

Consulting, process design, equipment manufacturing, cleanroom construction, water system installation, commissioning, IQ/OQ/PQ validation, technology transfer, and operator training.

Most turnkey injectable line projects are completed within 12–18 months from contract signing to production handover.

Yes — remote diagnostics, preventive maintenance programs, spare parts supply, and on-site service via regional teams.

Related Industry Solutions